Pharmacodynamics of T cell function for monitoring pharmacologic immunosuppression after allogeneic hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Pharmacodynamics of T cell function for monitoring pharmacologic immunosuppression after allogeneic hematopoietic stem cell transplantation

Published:2016-11-23 Issue:4 Volume:105 Page:497-505
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Martínez Carmen,Millán Olga,Rovira Montserrat,Fernández-Avilés Francesc,López Anna,Suárez-Lledó María,Carreras Enric,Urbano-Ispízua Álvaro,Brunet Mercè

Funder

Instituto de Salud Carlos III

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-016-2145-5.pdf

Reference35 articles.

1. Choi SW, Reddy P. Current and emerging strategies for the prevention of graft-versus-host disease. Nat Rev Clin Oncol. 2014;11:536–47.

2. Ruutu, T. Gratwohl A, de Witte T, Afanasyev B, Apperley J, Bacigalupo A, et al. Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice. Bone Marrow Transplant 2014;49:168–74.

3. Ruutu T, van Biezen A, Hertenstein B, Henseler A, Garderet L, Passweg J, et al. Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2012;47:1459–64.

4. Kahan BD. Therapeutic drug monitoring of cyclosporine: 20 years of progress. Transplant Proc. 2004;36(S1):S378–91.

5. Wood A, Maurer G, Neiderberger W, Beveridge T. Cyclosporine; pharmacokinetics, metabolism and drug interactions. Transplant Proc. 1983;15:2409–12.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Preliminary Investigation towards the Risk Stratification of Allogeneic Stem Cell Recipients with Respect to the Potential for Development of GVHD via Their Pre-Transplant Plasma Lipid and Metabolic Signature;Cancers;2019-07-25

2. Risk stratification of allogeneic stem cell recipients with respect to the potential for development of GVHD via their pre-transplant plasma lipid and metabolic signature;2018-11-20

3. Reconstituting donor T cells increase their biomass following hematopoietic stem cell transplantation;The Analyst;2018

4. Low T-Cell Responses to Mitogen Stimulation Predicts Poor Survival in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation;Frontiers in Immunology;2017-11-09